121 related articles for article (PubMed ID: 22401149)
1. Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis.
Drabik A; Büscher G; Thomas K; Graf C; Müller D; Stock S
Popul Health Manag; 2012 Aug; 15(4):241-7. PubMed ID: 22401149
[TBL] [Abstract][Full Text] [Related]
2. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
Drabik A; Graf C; Büscher G; Stock S
Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
[TBL] [Abstract][Full Text] [Related]
3. Is there a survival benefit within a German primary care-based disease management program?
Miksch A; Laux G; Ose D; Joos S; Campbell S; Riens B; Szecsenyi J
Am J Manag Care; 2010 Jan; 16(1):49-54. PubMed ID: 20148605
[TBL] [Abstract][Full Text] [Related]
4. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].
Joos S; Rosemann T; Heiderhoff M; Wensing M; Ludt S; Gensichen J; Kaufmann-Kolle P; Szecsenyi J
BMC Public Health; 2005 Oct; 5():99. PubMed ID: 16202151
[TBL] [Abstract][Full Text] [Related]
5. The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus - A Population-Based Retrospective Cohort Study.
Riedl R; Robausch M; Berghold A
PLoS One; 2016; 11(8):e0161429. PubMed ID: 27532885
[TBL] [Abstract][Full Text] [Related]
6. Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective.
Drabik A; Büscher G; Sawicki PT; Thomas K; Graf C; Müller D; Stock S
Diabetes Res Clin Pract; 2012 Feb; 95(2):194-200. PubMed ID: 22004943
[TBL] [Abstract][Full Text] [Related]
7. Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.
Kirsch F; Becker C; Schramm A; Maier W; Leidl R
Eur J Health Econ; 2020 Jun; 21(4):607-619. PubMed ID: 32006188
[TBL] [Abstract][Full Text] [Related]
8. [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].
Miksch A; Trieschmann J; Ose D; Rölz A; Heiderhoff M; Szecsenyi J
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):427-33. PubMed ID: 21843845
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.
Ostermann H; Hoess V; Mueller M
BMC Public Health; 2012 Jun; 12():490. PubMed ID: 22742209
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the Disease Management Program on HbA1c Value in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison between Disease Management Programs and Standard Care].
Wiefarn S; Kostev K; Heumann C; Rettelbach A
Dtsch Med Wochenschr; 2017 Oct; 142(21):e148-e155. PubMed ID: 28915520
[No Abstract] [Full Text] [Related]
11. Disease Management Program in patients with type 2 diabetes mellitus, long-term results of the early and established program cohort: A population-based retrospective cohort study.
Riedl R; Robausch M; Berghold A
PLoS One; 2022; 17(12):e0279090. PubMed ID: 36512601
[TBL] [Abstract][Full Text] [Related]
12. Disease management programmes for patients with coronary heart disease--an empirical study of German programmes.
Gapp O; Schweikert B; Meisinger C; Holle R
Health Policy; 2008 Dec; 88(2-3):176-85. PubMed ID: 18442868
[TBL] [Abstract][Full Text] [Related]
13. Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.
Wiefarn S; Heumann C; Rettelbach A; Kostev K
J Diabetes Sci Technol; 2017 Jul; 11(4):808-813. PubMed ID: 28300432
[TBL] [Abstract][Full Text] [Related]
14. [A pilot study to evaluate the DMP for coronary heart disease - Development of a methodology and first results].
Schulte T; Mund M; Hofmann L; Pimperl A; Dittmann B; Hildebrandt H
Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():54-9. PubMed ID: 26875036
[TBL] [Abstract][Full Text] [Related]
15. Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.
Röttger J; Blümel M; Busse R
BMC Health Serv Res; 2017 Apr; 17(1):246. PubMed ID: 28372554
[TBL] [Abstract][Full Text] [Related]
16. Costs of chronic disease management for newly insured adults.
Gilmer T
Med Care; 2011 Sep; 49(9):e22-7. PubMed ID: 21478774
[TBL] [Abstract][Full Text] [Related]
17. The Comparison of Matching Methods Using Different Measures of Balance: Benefits and Risks Exemplified within a Study to Evaluate the Effects of German Disease Management Programs on Long-Term Outcomes of Patients with Type 2 Diabetes.
Fullerton B; Pöhlmann B; Krohn R; Adams JL; Gerlach FM; Erler A
Health Serv Res; 2016 Oct; 51(5):1960-80. PubMed ID: 26841379
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an Electronic Health Record System With a Disease Management Program and Health Care Treatment Costs for Danish Patients With Type 2 Diabetes.
Pulleyblank R; Mellace G; Olsen KR
JAMA Netw Open; 2020 May; 3(5):e206603. PubMed ID: 32453386
[TBL] [Abstract][Full Text] [Related]
19. Effects of a population-based diabetes management program in Singapore.
Tan WS; Ding YY; Xia WC; Heng BH
Am J Manag Care; 2014 Sep; 20(9):e388-98. PubMed ID: 25364875
[TBL] [Abstract][Full Text] [Related]
20. [The methods within the evaluation of disease management programmes in control-group designs using the example of diabetes mellitus - a systematic literature review].
Drabik A; Sawicki PT; Müller D; Passon A; Stock S
Gesundheitswesen; 2012 Aug; 74(8-9):496-501. PubMed ID: 22454226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
